Endocrinology, Diabetes & Metabolism Doctors in Rancho Mirage, CA Accepting Medicare

4 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 4

Helen L. Baron, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 39000 Bob Hope Dr, Rancho Mirage, CA 92270 Phone: 760-321-5257    Fax: 760-773-1631

Elke Jost-vu, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 39000 Bob Hope Dr Ste K-114, Rancho Mirage, CA 92270 Phone: 760-321-5257    Fax: 760-773-1631

Dr. Mohamad Khaldoun Alnabelsi, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 39000 Bob Hope Dr, K208, Rancho Mirage, CA 92270 Phone: 760-773-5350    Fax: 760-773-0098

Wendy White, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 39000 Bob Hope Dr Ste K-114, Rancho Mirage, CA 92270 Phone: 760-321-5257    Fax: 760-773-1361

News Archive

Study: Preoperative interventions improve outcomes of patients undergoing CABG surgery

A quality improvement initiative improved the outcomes of patients undergoing cardiac surgery at select medical centers in northern New England, according to a study in the December issue of Critical Care Nurse (CCN).

Childhood abuse and neglect associated with worse executive function in adulthood

The scars of childhood abuse and neglect affect adults' brains for decades to come - including their ability to process and act on information both quickly and accurately, new research suggests.

Governments tackle interpersonal violence

Governments around the world are taking new and stronger measures to quell interpersonal violence and its life-long health consequences, a new WHO report shows.

Alkermes commences ALKS 5461 phase 1/2 study for treatment-resistant depression

Alkermes, Inc. today announced the initiation of a phase 1/2 study of ALKS 5461 for treatment-resistant depression (TRD). ALKS 5461 is the combination of ALKS 33, a proprietary opioid modulator, and buprenorphine. TRD, which is also known as refractory depression, refers to depressive episodes that are not adequately controlled by standard antidepressant therapy.

Study links low maternal folate levels with attention-deficit/hyperactivity problems in children

It has long been suggested that healthy folate (the natural form of folic acid) levels in expectant mothers goes hand in hand with healthy nervous system development in their children. A study published in an upcoming issue of the Journal of Child Psychology and Psychiatry finds that low maternal folate levels is linked to the development of attention-deficit/hyperactivity problems in children at age seven to nine years.

Read more Medical News

› Verified 5 days ago